Saurabh Saha - 31 Mar 2023 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role: Chief Executive Officer, Director
Signature: /s/ Gregory Weinhoff, attorney-in-fact
Issuer symbol: CNTA
Transactions as of: 31 Mar 2023
Net transactions value: -$85,851
Form type: 4
Filing time: 04 Apr 2023, 17:03:59 UTC
Previous filing: 03 Feb 2023
Next filing: 08 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNTA	Ordinary Shares	Tax liability	$85,851	-22,013	-2.4%	$3.90	895,362	31 Mar 2023	Direct	F1, F2
holding	CNTA	Ordinary Shares						38,000	31 Mar 2023	By trust	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2	Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
F3	These shares are held directly in a trust, for which the reporting person and his spouse serve as trustees.

Remarks:

Exhibit 24 - Power of Attorney